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Abstract
The key concern for public health is that bacterial strains isolated from various ecosystems are immune to 
antibiotics used in human medicine, thus dramatically limiting therapeutic options and threatening the lives of 
infected people. The present study aims to reveal the antibiotics profile of fiftysix isolates of local thermophilic 
Bacillus licheniformis isolated from different environmental soil sites in Maysan city, Iraq. The antimicrobial agent 
resistance profile of B. licheniformis isolates was performed using the disc diffusion assay according to Kirby-
Bauer susceptibility test protocol. The results showed that isolates were resistance against cefepime (n=56; 
100%), amoxicillin (n=13; 23.3%) and ampicillin (n=52; 92.9%); and intermediate (n=56; 100%) against cephalothin 
and naldixic acid. The percentage resistance was low for aztreonam (n=4; 7%), chloramphenicol (n=3; 5%), 
clotrimazole (n=6; 10%), novobiocin (n=2; 3.5%) and ticarcillin (n=3; 5%). On the other hand, all isolates were 
sensitive (n=56; 100%) towards the following antibiotics: amikacin, ceftazidime, ciprofloxacin, clindamycin, 
imipenem, netilmycin, gentamicin, nitrofurantion, rifampin, trimethoprim and vancomycin. The results of this 
study suggest that the Iraqi thermophilic B. licheniformis isolates are variable in their susceptibility towards the 
standards antimicrobial agents. Furthermore, the presence of cefepime, amoxicillin, ampicillin, cephalothin and 
naldixic resistant isolates of B. licheniformis in Iraqi soils is of concern about how resistance could spread to other 
bacteria, and ultimately to humans.
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Introduction 
Bacillus licheniformis named by Weigmann 1898, 
is a Gram positive facultative, anaerobic, rod shaped and 
endospore-forming bacterium. The strains of this species 
are Widely distributed throughout the ecosystem as a 
saprophytic, where harsh conditions survive in the form 
of highly resistant endospores and belong to the Bacillus 
subtilis group (Garrity et al., 2009; Logan & Vos, 2015). 
Because of its ability to grow in a thermal environment 
like a hot spring, the bacterium is known to be facultative 
thermophilic or thermotolerant microorganism (Rodríguez-
Lozano et al., 2010; Fritze, 2004).
It has generation time of 22min at 55°C compared 
to 41min at 37°C (Bischoff et al., 2006). B. licheniformis 
has been known to produce diverse substances that are 
useful in industries such as α-amylase, β-galactosidase, 
alkaline protease, anti-biofilm, and keratinase (Lin et al., 
1992; Declerck et al., 2002; Sellami-Kamoun et al., 2008; 
Juajun et al., 2011; Sayem et al., 2011). While generally 
considered safe, there have been reports of occasional 
cases of Bacillus licheniformis-associated systemic 
infections in humans (Santini et al., 1995). However, 
without prior lesions it has no potential to penetrate 
the body ‘s outer barriers. However, abortions in sheep 
and cattle have been documented, and it has been 
demonstrated experimentally that Bacillus licheniformis is 
capable of infecting bovine placenta (Syrjälä et al., 2007; 
Agerholm et al., 1999).
Reported cases have suggested that lichenysin 
is produced in most strains of B. licheniformis. Bacillus 
licheniformis-associated food poisoning lichenysin has 
been characterized by a relatively short incubation 
period (2–14h) and a high dose of infection (> 105 CFUg-1) 
accompanied by mild gastrointestinal symptoms lasting 
6–24h (Salkinoja-Salonen et al., 1999; Madslien et al., 2013). 
Lichenysin is an important cyclic lipopeptide against 
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the yeast (Noudeh et al., 2010; Kashid & Ghosh, 2010). 
Diarrhea is caused by food poisoning, but in half of the 
confirmed cases, vomiting occurs (Ara et al., 2007). One 
case of fatal illness associated with infant milk powder 
infected with Bacillus licheniformis has been reported 
(Mikkola et al., 2000; Salkinoja-Salonen et al., 1999). 
In the past few years, the emergence of antibiotic 
resistance among bacteria has increased and its possible 
public health consequences have resulted in enhanced 
bacterial resistance surveillance in many countries. 
Bacillus licheniformis strains have received relatively little 
recognition for their antibiotic resistance; this may be due 
to their role as non-pathogenic species. Bacilli resistance 
to various antibiotics has been previously established, 
and it has been shown that species can be classified in 
theory on the basis of the results of their susceptibility tests 
(Reva et al.,1995). 
The MIC test for some antibiotics was determined 
for strains of Bacillus licheniformis which were isolated 
from starters for the production of Sudanese bread. The 
MIC test was susceptible to tetracycline (8.0 mg / litre), 
vancomycin (4.0 mg / litre), and gentamicin (4.0 mg 
/ litre), but was streptomycin resistant (Adimpong et 
al., 2012). Moreover, disc diffusion assay was reported 
for antibiotic resistance profiles in the genus of Bacillus 
particularly for B. cereus (Gao et al., 2018; Fiedler et al., 
2019; Park et al., 2020), in contrast very few was reported 
for B. licheniformis (Jeong et al., 2017; Meneghetti et al., 
2018). Because of the limitation of data which is available 
about the resistance of B. licheniformis and to provide 
a guidance value to clinicians encountering possibly B. 
licheniformis infections; this study was aimed to detect 
the antibiotic resistance profile of local thermophilic B. 
licheniformis isolated from soil in Maysan Province, Iraq. 
Material and Methods 
Fifty six isolates of thermophilic Bacillus licheniformis 
that isolated and confirmed from the previous study 
(Banoon & Ali, 2018) were included in this study. In brief, 
two grams of soil were added to 10 ml distilled water 
and mixed well, after a while 0.25 ml from soil suspension 
was transferred to 25 ml of Lauria broth medium and 
incubated at 55°C for 18 hours. Series of dilutions up to 
10-3 were prepared for each sample. Each dilution was 
cultured on Lauria agar medium and incubated at 55°C 
for 18 hours. Upon growing, one colony was picked up 
from fresh overnight agar plates then cultured on a fresh 
Lauria agar medium and incubated at 65°C for confirming 
the tolerance of high temperatures (as thermophilic). 
For the identification of B. licheniformis isolates, 
VITEK-2 compact system using BCL cards and gyrase B 
gene were used. The antibiotic-resistant of B. licheniformis 
strains was conducted using the disc diffusion method 
(Bauer et al., 1966). A pure culture of B. licheniformis was 
prepared by adding a growth from an isolated colony to 
5 ml of sterile normal saline in a cell density equivalent to 
McFarland tube turbidity No. (0.5) which is approximately 
equal to a density of 1.5x108 CFU/ml of bacterial cells. 
A sterile cotton swab was used to Adding -from 
bacterial suspension to be streaked on Muller-Hinton 
medium. Twenty seven antibiotic discs (Al-Razi, Iraq) 
were tested, including amikacin (AMK, 30 µg/disc), 
amoxicillin (AMX, 25 µg/disc), amoxicillin-clavulanic acid 
(AMC, 20 µg/10 µg/disc), ampicillin (AMP, 10 µg/disc), 
aztreonam (ATM, 30 µg/disc), cefepime (FEP, 30 µg/disc), 
ceftazidime (CAZ, 30 µg/disc), cephalothin (CEF, 30 µg/
disc), chloramphenicol (CHL, 30 µg/disc), ciprofloxacin 
(CIP, 5 µg/disc), clindamycin (CLI, 2 µg/disc), clotrimazole 
(CC, 10 µg/disc), erythromycin (ERY, 15 µg/disc), 
gentamicin (GEN, 10 µg/disc), imipenem (IPM, 10 µg/disc), 
kanamycin (KAN, 30 µg/disc), nalidixic acid (NAL, 30 µg/
disc), netilmycin (NET, 30 µg/disc), nitrofurantoin (NIT, 300 
µg/disc), novobiocin (NV, 30 µg/disc), oxacillin (OXA, 1 
µg/disc), piperacillin (PIP, 100 µg/disc), rifampin (RIF, 5 µg/
disc), ticarcillin (TIC, 75 µg/disc), ticarcillin-clavulanic acid 
(TIM, 75 µg/10 µg/disc ), trimethoprim (TMP, 5 µg/disc) and 
vancomycin (VAN, 30 µg/disc). The discs were placed on 
the surface of the medium at evenly spaced intervals 
with flaming sterile forceps. The plates were incubated at 
37 °C for 18 hr. For each antibiotic the inhibition zone was 
measured using a ruler. 
The presence of a clear zone around the disk 
has been the index of antibiotic sensitivity. The antibiotic 
sensitivity test results were determined by the diameter of 
the inhibition zone (Barry, 1986; Çetin & Gurler, 1989). 
The absence of such a clear zone or the presence 
of some colonies within the clear zone indicated that the 
strains collected were resistant to that antibiotic test.
Results and Discussion 
All isolated B. licheniformis strains were tested for 
their antibiotic resistance against a set of antimicrobial 
agents using Kirby-Bauer disk diffusion method. The 
Figure (1) showed that all strains were highly sensitive 
(n=56; 100 %) towards the following antibiotics: amikacin, 
ceftazidime, ciprofloxacin, clindamycin, imipenem, 
netilmycin, gentamicin, nitrofurantion, rifampin, 
trimethoprim and vancomycin. However, these results 
were compatible with studies of (Weber et al., 1988; De 
Clerck & De Vos, 2004). In contrast, all isolates showed 
resistance to cefepime (n=56; 100 %) and intermediate 
(n=56; 100 %) to cephalothin and naldixic acid. 
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Others antibacterial agents were varied in their 
effects in different ways where the isolates showed 
resistance against amoxicillin (n=13; 23.3%) and ampicillin 
(n=52; 92.9%). Moreover, the results showed that the 
percentage resistance was low for aztreonam (n=4; 
7%), chloramphenicol (n=3; 5%), clotrimazole (n=6; 10%), 
novobiocin (n=2; 3.5%) and ticarcillin (n=3; 5%).
Figure 1. Antibiotic sensitivity profile of Bacillus licheniformis based on inhibition zone diameter (mm); (green) resistance, (red) 
intermediate, (blue) sensitive.
There are few studies that showed the sensitivity 
of Bacillus species to antibiotics even though they are 
related to the genus taxonomy. Banerjee et al., (2007) has 
noticed that B. licheniformis strains were 100% susceptible 
to oxytetracycline, gentamicin and chloramphenicol 
and 40% were susceptible to bacitracin. Penicillin G has 
been reported to be less active against B. licheniformis 
(Weber et al., 1988). 
A study carried out by Abdel-Shakour & Roushdy 
(2010) of Thermo tolerant soil isolate of Bacillus cereus BC2, 
found that the strain was resistant to the Ampicillin and 
Amoxycillin while sensitive to the Erythromycin, Amikacin, 
Chloramphenicol, and Kanamycin. Another study done 
by Sarker et al., (2010) for Bacillus thuringiensis strains 
from dump soil showed that the strains were sensitive to 
erythromycin, chloramphenicol, kanamycin, ampicillin, 
and vancomycin. On the other hand, when checked by 
the method of disc diffusion on the nutrient agar plate, 
the strains showed resistance to amoxicillin, as verified by 
the method of antibiotic spread plate. Previous studies 
showed that Vancomycin is bactericidal at or near the 
same concentration at which it is bacteriostatic (Weber 
et al., 1988). Almost all strains in our study were resistant 
to ampicillin (n=52; 92.9 %), this was in agreement with a 
previous study (Andrews & Wise, 2002). 
The Chloramphenicol inhibits protein synthesis 
by binding to the ribosomal subunit of the 50s and 
blocking the peptidyltransferase reaction. By binding to 
the ribosome and preventing translocation, gentamycin 
inhibits protein synthesis. Rifampin prevents transcription 
initiation by binding RNA polymerase to the ß subunit of 
the prokaryotes (Harvey & Ferrier, 2011). 
Kanamycin prevents protein synthesis by binding 
to and preventing translocation from the ribosomal 
subunit of the 30s. Timentin is a combination of the 
penicillin derivative Ticarcillin and the B-lactamase 
inhibitor, clavulanic acid the exogenous ß-lactamase 
is inactivated by the clavulanic acid, which enables 
Ticarcillin to prevent the growth of any sensitive cells in the 
population. Trimethoprim is an inhibitor of the reductase 
in bacterial dihydrofolic acid (Zähner & Maas, 1972). In 
the study carried out by (Ozkocaman et al., 2006), the 
author showed that B. licheniformis isolates were resistant 
to Clindamycin, penicillin and other B-lactam agents, 
whilst aztreonam, Imipenem, cefepime, ciprofloxacin, 
meropenem, levofloxacin, ofloxacin, tetracycline and 
Vancomycin remained fully active. 
A study was done by Bautista & Teves (2013) for 
B. thuringiensis, which isolated from vermicast a loam 
soil which considered as non-pathogenic for humans 
and used extensively for pest control, was found to be 
resistant to the β-lactams (amoxicillin and ampicillin). 
Ampicillin and amoxicillin belong closely to a class of 
antibiotics called penicillins which are used to treat 
bacterial infections. Such antibiotics have a common 
mechanism of action by preventing bacterial cells from 
multiplying because the walls that surround them are not 
forming. Although the results of this study have illustrated 
susceptibility to the most tested antimicrobial agents, 
several recent studies have been shown increasing in 
resistance of B. licheniformis strains towards antibiotics 
(Adimpong et al., 2012; Agersø et al., 2018; Agersø et al., 
2019; Moore et al., 2019). 
Cefepime is a broad-spectrum β-lactam 
antibiotic that has been introduced in the market for the 
treatment of serious bacterial infections particularly for the 
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treatment of Gram-negative bacteria (Gupta et al., 2006; 
Donà et al., 2019). Surprisingly, all the isolates in our study 
were resistant toward cefepime. However, some Gram-
positive bacteria including Streptococcus pneumoniae, 
Streptococcus thermophilus, Enterococcus faecium, 
and Staphylococcus aureus have developed several 
mechanisms for β-lactam resistance (Fisher & Mobashery, 
2016; Lemonidis et al., 2019; Aldujaili, & Banoon, 2020).
In the genus of Bacillus resistance towards 
β-lactam antibiotics was also reported. Fenselau et al. 
(2008) reported that B. cereus 5/B line (ATCC 13061) was 
resistant towards β-lactam antibiotics. In B. licheniformis 
mechanism of resistance has been observed by the 
production of BlaP b-lactamase (Vandevenne et al., 
2007) and the peptidoglycan fragment that triggers 
β-lactam resistance (Amoroso et al., 2012). In addition, 
the resistance found to cephalothin and nalidixic acid 
is not surprising as it coincides to what has been found 
in several studies (Barry & Jones, 1984; Akinbowale et al., 
2006; Crowe-McAuliffe et al., 2018). In a study carried out 
by Shale & Malebo (2011), the authors found that 97% 
of the B. cereus isolates (n=90) were resistant to nalidixic 
acid. 
Conclusion
The study concludes the high prevalence of B. 
licheniformis and its antibiotic resistance characteristics 
in Iraqi soils. The resistance of isolates to cefepime, 
cephalothin, naldixic, amoxicillin, ampicillin, aztreonam, 
chloramphenicol, clotrimazole, novobiocin and 
ticarcillin has shown that such antibiotics should not be 
used in human therapy without prior determination of 
susceptibility. 
Moreover, where the antibiotic resistance of 
the bacterial strains usually results from chromosome 
mutations or from the acquisition of resistance plasmids 
(Inglis, 1999; Balakrishnan et al., 2003), the use of antibiotics 
for humans needs to be regulated strongly to minimize the 
opportunity for microorganisms to develop resistance.
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